New initiative to focus on exchange progress

A new initiative aims to unite the industry to provide a standardized framework for connectivity.

Healtheway, the nonprofit public/private collaborative chartered to advance the nationwide implementation of interoperable health information exchange, announced Carequality during the Health Information and Management Systems Society’s annual conference.

Carequality is an open, transparent and inclusive industry-driven effort, according to a release. It will convene stakeholders and facilitate industry consensus to develop and maintain a standards-based interoperability framework that enables information exchange between and among networks.

“The new frontier in achieving nationwide, secure health data exchange involves building upon all of the existing great work across various consortia and networks, and tying it all together into a unified approach for the industry,” said Mariann Yeager, Healtheway’s executive director. “A group of organizations–-including many of those most active today in achieving nationwide interoperability–-approached Healtheway about serving as the neutral convener for industry stakeholders to come together. Together they will work through implementation-level issues to enable exchange between and among networks."

Twenty-six organizations from across the care spectrum--including Epic, Kaiser Permanente, Walgreens and Intermountain Healthcare--have signed on as founding members and another 16 entities have expressed support for the project.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.